U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984484) titled 'Performance and Safety of Afluxin(R) in Patients With Gastroesophageal Reflux Disease' on May 14.
Brief Summary: Gastroesophageal Reflux Disease (GERD) is a chronic condition in which stomach acid flows back into the esophagus, causing irritation and inflammation. GERD is categorized into Nonerosive Reflux Disease (NERD), Erosive Esophagitis (EE), and Barrett's esophagus (BE). Common symptoms include heartburn and acid regurgitation. Lifestyle factors such as smoking, obesity, and Helicobacter pylori infection can increase the risk of developing GERD. The clinical management of GERD typically involves Proton Pump Inhibitors (PPIs) th...